Cabinet de biologie médicale Dr HARDY
0632.785.438 · rovalta.com · 28/09/2026
NORMAL SITUATION
Cabinet de biologie médicale Dr HARDY
Company — Normal situation.
Financial year 2024 · Closed on 31/12/2024
Net result114,5 k €+73,2 %over 1 year
Gross margin172,6 k €+33,0 %over 1 year
Equity417,8 k €+37,7 %over 1 year
Overview
Identity
Source · BCE/KBOCabinet de biologie médicale Dr HARDY is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0632.785.438
- Legal form
- Private limited company
- Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2024
Signals
ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 10 filingsTrend over 10 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 172,6 k € | +33.0% | 129,8 k € | -35.9% | 202,6 k € | +9.9% | 184,4 k € | +28.7% | 143,3 k € |
| EBITDA | 171,7 k € | +33.2% | 128,9 k € | -36.1% | 201,8 k € | +9.9% | 183,6 k € | +28.8% | 142,5 k € |
| Operating result | 169,4 k € | +83.1% | 92,5 k € | -41.3% | 157,6 k € | +11.4% | 141,6 k € | +41.5% | 100 k € |
| Net result | 114,5 k € | +73.2% | 66,1 k € | -39.8% | 109,8 k € | +8.8% | 100,9 k € | +27.4% | 79,2 k € |
| Balance sheet | |||||||||
| Equity | 417,8 k € | +37.7% | 303,4 k € | +27.9% | 237,3 k € | +55.9% | 152,2 k € | +197% | 51,3 k € |
| Total assets | 420,8 k € | +33.6% | 314,9 k € | -1.7% | 320,4 k € | -38.1% | 517,4 k € | +15.1% | 449,3 k € |
| Cash | 287,5 k € | +75.7% | 163,7 k € | +12.5% | 145,5 k € | -53.4% | 312,5 k € | +49.2% | 209,4 k € |
| Debts | 3 k € | -74.1% | 11,6 k € | -86.1% | 83,1 k € | -77.2% | 365,2 k € | -8.2% | 398,1 k € |
Board of directors
Source · NBB, accounts to 31/12/20241 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Marie-Andrée HARDY | DirectorManagerended |
Financials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 17/07/2025 | 27/06/2024 | 20/06/2023 | 27/07/2022 | 27/07/2021 | 22/06/2020 |
| General meeting | 28/02/2025 | 21/06/2024 | 16/06/2023 | 17/06/2022 | 18/06/2021 | 19/06/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 10 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2024 | 28/02/2025 | 17/07/2025 | French | |
| Micro model | 31/12/2023 | 21/06/2024 | 27/06/2024 | French | |
| Micro model | 31/12/2022 | 16/06/2023 | 20/06/2023 | French | |
| Micro model | 31/12/2021 | 17/06/2022 | 27/07/2022 | French | |
| Micro model | 31/12/2020 | 18/06/2021 | 27/07/2021 | French | |
| Micro model | 31/12/2019 | 19/06/2020 | 22/06/2020 | French | |
| Micro model | 31/12/2018 | 21/06/2019 | 14/08/2019 | French | |
| Micro model | 31/12/2017 | 15/06/2018 | 17/08/2018 | French | |
| Micro model | 31/12/2016 | 16/06/2017 | 04/08/2017 | French | |
| Abridged model | 31/12/2015 | 17/06/2016 | 20/06/2016 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20241 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Marie-Andrée HARDY | DirectorManagerended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Dissolution22/05/2025DISSOLUTION ET LIQUIDATION EN UN SEUL ACTE
- Mandates04/10/2023STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS
- Mandates26/10/2016SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
- Other02/02/2016DIVERS
- Other30/06/2015RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Name
Registered office
Annual accounts
Filings10 filings
201520162017201820192020202120222023202420252026
CABINET DE BIOLOGIE MEDICALE DR HARDY
Rue du Plateau 12 bte 31, 5100 Jambes (Namur)
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Rue du Plateau 12 bte 31, 5100 Jambes (Namur) | accounts 2021 → 2024 | Accounts 2024 · 2025-00291401 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| CABINET DE BIOLOGIE MEDICALE DR HARDY | accounts 2021 → 2024 | Accounts 2024 · 2025-00291401 |
Events
- 2024Annual accounts 2024114,5 k €↑
- 2023Annual accounts 202366,1 k €↓
- 2022Annual accounts 2022109,8 k €↑
- 2021Annual accounts 2021100,9 k €↑
- 2020Annual accounts 202079,2 k €↑
- 2019Annual accounts 201954,4 k €↑
- 2018Annual accounts 201847,9 k €↑
- 2017Annual accounts 20176 k €↑
- 2016Annual accounts 2016-159 k €↓
- 2015Annual accounts 201510,4 k €